SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001144204-12-006433
Filing Date
2012-02-07
Accepted
2012-02-07 17:17:01
Documents
1
Effectiveness Date
2012-02-07
Items
Item 06: Rule 506

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 11174
  Complete submission text file 0001144204-12-006433.txt   12318
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANADA A1 M5J 2G2 4163642551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0731
Type: D | Act: 33 | File No.: 021-173040 | Film No.: 12578754
SIC: 2834 Pharmaceutical Preparations